LipoScience, Inc.

Patent Applications and Registrations

Patent applications and USPTO patent grants for LipoScience, Inc..The latest application filed is for "cardiovascular risk evaluations using a risk parameter that includes an hdl and inflammatory biomarker interaction parameter".

Company Profile

21.49.50

LipoScience, Inc. - Morrisville NC
LipoScience, Inc. - Raleigh NC US
LipoScience, Inc. -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks

Patent Activity

Patent	Date
Cardiovascular Risk Evaluations Using a Risk Parameter That Includes an HDL and Inflammatory Biomarker Interaction Parameter App 20220137076 - Otvos; James D. ; et al.	2022-05-05
Multi-Parameter Metabolic Vulnerability Index Evaluations App 20220043013 - Otvos; James D. ; et al.	2022-02-10
NMR Analyzers for Clinical Evaluation of Biosamples App 20220043086 - Otvos; James D. ; et al.	2022-02-10
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter Grant 11,231,429 - Otvos , et al. January 25, 2	2022-01-25
Methods To Predict Liver Disease Mortality Using Lipoprotein Lp-z App 20220011388 - Jiang; Zhenghui Gordon ; et al.	2022-01-13
Multi-parameter metabolic vulnerability index evaluations Grant 11,156,621 - Otvos , et al. October 26, 2	2021-10-26
NMR analyzers for clinical evaluation of biosamples Grant 11,156,685 - Otvos , et al. October 26, 2	2021-10-26
Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes App 20210304898 - Otvos; James D. ; et al.	2021-09-30
Methods and systems for predicting colorectal cancer incidence and mortality Grant 11,124,837 - Otvos , et al. September 21, 2	2021-09-21
Multiple-marker risk parameters predictive of conversion to diabetes Grant 11,037,683 - Otvos , et al. June 15, 2	2021-06-15
NMR Measurements of NMR Biomarker GlycA App 20210080452 - Otvos; James D. ; et al.	2021-03-18
NMR measurements of NMR biomarker GlycA Grant 10,852,293 - Otvos , et al. December 1, 2	2020-12-01
NMR Quantification of TMAO App 20200355634 - Otvos; James D. ; et al.	2020-11-12
NMR quantification of TMAO Grant 10,613,044 - Otvos , et al.	2020-04-07
Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements App 20200066370 - Otvos; James D.	2020-02-27
CHD Risk Stratification Evaluations for Subjects With High Levels of Large HDL-P App 20200003752 - Otvos; James D. ; et al.	2020-01-02
Multi-Parameter Diabetes Risk Evaluations App 20200005943 - Otvos; James D. ; et al.	2020-01-02
Methods, systems and computer programs for assessing CHD risk using adjusted HDL article number measurements Grant 10,504,610 - Otvos Dec	2019-12-10
NMR Analyzers for Clinical Evaluation of Biosamples App 20190317165 - Otvos; James D. ; et al.	2019-10-17
CHD risk stratification evaluations for subjects with high levels of large HDL-P Grant 10,386,355 - Otvos , et al. A	2019-08-20
Multi-parameter diabetes risk evaluations Grant 10,388,414 - Otvos , et al. A	2019-08-20
NMR analyzers for clinical evaluation of biosamples Grant 10,365,339 - Otvos , et al. July 30, 2	2019-07-30
Methods and Systems to Detect and Quantify the Amount of LP-X and Other Abnormal Lipoproteins in a Biosample Using NMR Spectrosc App 20190145990 - Otvos; James D. ; et al.	2019-05-16
Multi-Parameter Metabolic Vulnerability Index Evaluations App 20190072572 - Otvos; James D. ; et al.	2019-03-07
Cardiovascular Risk Evaluations Using a Risk Parameter that Includes an HDL and Inflammatory Biomarker Interaction Parameter App 20180196075 - Otvos; James D. ; et al.	2018-07-12
Multiple-Marker Risk Parameters Predictive of Conversion to Diabetes App 20180158554 - Otvos; James D. ; et al.	2018-06-07
Methods and Systems for Predicting Colorectal Cancer Incidence and Mortality App 20180112274 - Otvos; James D. ; et al.	2018-04-26
Cardiovascular risk evaluations using a risk parameter that includes an HDL and inflammatory biomarker interaction parameter Grant 9,952,232 - Otvos , et al. April 24, 2	2018-04-24
Multiple-marker risk parameters predictive of conversion to diabetes Grant 9,928,345 - Otvos , et al. March 27, 2	2018-03-27
Multi-parameter diabetes risk evaluations Grant 9,792,410 - Otvos , et al. October 17, 2	2017-10-17
Quantitative NMR Clinical Analyzers With Automatic NMR Temperature Sensitivity Compensation that Accommodate Large Ambient Operational Temperature Ranges App 20170293007 - Morgan; David R. ; et al.	2017-10-12
Nmr Quantification Of Tmao App 20170184521 - Otvos; James D. ; et al.	2017-06-29
Quantitative NMR clinical analyzers with automatic NMR temperature sensitivity compensation that accommodate large ambient operational temperature ranges Grant 9,689,942 - Morgan , et al. June 27, 2	2017-06-27
Methods, Systems and Computer Programs for Assessing CHD Risk Using Adjusted HDL Particle Number Measurements App 20170083663 - Otvos; James D.	2017-03-23
CHD Risk Stratification Evaluations for Subjects with High Levels of Large HDL-P App 20170017772 - OTVOS; JAMES D. ; et al.	2017-01-19
NMR quantification of TMAO Grant 9,541,620 - Otvos , et al. January 10, 2	2017-01-10
NMR Measurements of NMR Biomarker GlycA App 20170003269 - Otvos; James D. ; et al.	2017-01-05
NMR quantification of TMAO Grant 9,535,144 - Otvos , et al. January 3, 2	2017-01-03
Multi-Parameter Diabetes Risk Evaluations App 20160321424 - Otvos; James D. ; et al.	2016-11-03
Protective HDL particle number evaluations Grant 9,483,611 - Otvos , et al. November 1, 2	2016-11-01
CHD risk stratification evaluations for subjects with high levels of large HDL-P Grant 9,483,612 - Otvos , et al. November 1, 2	2016-11-01
NMR measurements of NMR biomarker GlycA Grant 9,470,771 - Otvos , et al. October 18, 2	2016-10-18
Methods, systems and computer programs for assessing CHD risk using adjusted HDL particle number measurements Grant 9,435,870 - Otvos September 6, 2	2016-09-06
Multi-parameter diabetes risk evaluations Grant 9,361,429 - Otvos , et al. June 7, 2	2016-06-07
Cardiovascular Risk Evaluations Using A Risk Parameter That Includes An Hdl And Inflammatory Biomarker Interaction Parameter App 20160077116 - Otvos; James D. ; et al.	2016-03-17
Nmr Quantification Of Tmao App 20150149094 - Otvos; James D. ; et al.	2015-05-28
Multi-parameter Diabetes Risk Evaluations App 20150149095 - Otvos; James D. ; et al.	2015-05-28
Multiple-marker Risk Parameters Predictive Of Conversion To Diabetes App 20150127267 - Otvos; James D. ; et al.	2015-05-07
Nmr Analyzers For Clinical Evaluation Of Biosamples App 20140184223 - Otvos; James D. ; et al.	2014-07-03
NMR analyzers for clinical evaluation of biosamples Grant 8,704,521 - Otvos , et al. April 22, 2	2014-04-22
Multi-parameter Diabetes Risk Evaluations App 20130332082 - Otvos; James D. ; et al.	2013-12-12
Nmr Measurements Of Glyca App 20130328561 - Otvos; James D. ; et al.	2013-12-12
Nmr Quantification Of Tmao App 20130325353 - Otvos; James D. ; et al.	2013-12-05
Protective Hdl Particle Number Evaluations App 20130289884 - Otvos; James D. ; et al.	2013-10-31
Chd Risk Stratification Evaluations For Subjects With High Levels Of Large Hdl -p App 20130289885 - Otvos; James D. ; et al.	2013-10-31
Lipoprotein insulin resistance indexes and related methods, systems and computer programs for generating same Grant 8,386,187 - Otvos February 26, 2	2013-02-26
NMR clinical analyzers and related methods, systems, modules and computer program products for clinical evaluation of biosamples Grant 8,013,602 - Otvos , et al. September 6, 2	2011-09-06
Methods, systems and computer programs for assessing CHD risk using adjusted LDL particle number measurements Grant 7,790,465 - Otvos September 7, 2	2010-09-07
Methods, Systems And Computer Programs For Assessing Chd Risk Using Adjusted Hdl Particle Number Measurements App 20070264677 - Otvos; James D.	2007-11-15
NMR Measurement of Clinically Relevant Ionized Biosample Constituents Such As Ionized Calcium and/or Magnesium App 20070178598 - Jeyarajah; Elias ; et al.	2007-08-02
Methods, systems and computer programs for deconvolving the spectral contribution of chemical constituents with overlapping signals Grant 7,243,030 - Reeve , et al. July 10, 2	2007-07-10
Methods for providing personalized lipoprotein-based risk assessments Grant 6,653,140 - Otvos November 25, 2	2003-11-25
Method of determining presence and concentration of lipoprotein X in blood plasma and serum Grant 6,617,167 - Otvos , et al. September 9, 2	2003-09-09
Methods, systems, and computer program products for analyzing and presenting NMR lipoprotein-based risk assessment results Grant 6,576,471 - Otvos June 10, 2	2003-06-10
Methods and computer program products for determining risk of developing type 2 diabetes and other insulin resistance related disorders Grant 6,518,069 - Otvos , et al. February 11, 2	2003-02-11

Company Registrations

NCAGE Code	1XZU0	LIPOSCIENCE, INC.!DBA LIPO PROTEIN AND METABOLIC!DISORDER
CAGE Code	1XZU0	LIPOSCIENCE, INC. LIPO PROTEIN AND METABOLIC DISORDER
DUNS	012220914	LIPOSCIENCE, INC.
SEC	0001168197	LIPOSCIENCE INC of DELAWARE

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.